UFP Technologies, Inc. $UFPT Shares Acquired by Trexquant Investment LP

Key Points

• Trexquant Investment LP increased its holdings in UFP Technologies by 308.3% during the first quarter, owning 4,981 shares valued at approximately $1.01 million by the end of the quarter.
• UFP Technologies reported $2.50 earnings per share for the latest quarter, exceeding analysts' estimates, with a revenue increase of 37.2% year-over-year.
• Wall Street analysts have given UFP Technologies a consensus rating of "Moderate Buy" with an average price target of $289.00.

Trexquant Investment LP lifted its position in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 308.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,981 shares of the industrial products company's stock after purchasing an additional 3,761 shares during the period. Trexquant Investment LP owned about 0.06% of UFP Technologies worth $1,005,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Lazard Asset Management LLC acquired a new position in shares of UFP Technologies in the 4th quarter valued at $84,000. Park Square Financial Group LLC acquired a new position in UFP Technologies during the fourth quarter worth $107,000. CreativeOne Wealth LLC acquired a new position in UFP Technologies during the first quarter worth $203,000. Dakota Wealth Management acquired a new position in UFP Technologies during the first quarter worth $204,000. Finally, Envestnet Portfolio Solutions Inc. raised its position in UFP Technologies by 25.8% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 1,033 shares of the industrial products company's stock worth $208,000 after acquiring an additional 212 shares during the period. 87.28% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital upped their price objective on shares of UFP Technologies from $252.00 to $289.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $289.00.

UFP Technologies Price Performance

Shares of NASDAQ UFPT traded down $2.05 during mid-day trading on Friday, reaching $199.32. The company's stock had a trading volume of 149,860 shares, compared to its average volume of 94,124. The stock has a 50-day moving average of $223.21 and a two-hundred day moving average of $223.00. The stock has a market capitalization of $1.54 billion, a P/E ratio of 23.10 and a beta of 1.20. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.53 and a current ratio of 2.77. UFP Technologies, Inc. has a 1-year low of $178.26 and a 1-year high of $366.41.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last issued its earnings results on Monday, August 4th. The industrial products company reported $2.50 EPS for the quarter, beating analysts' consensus estimates of $2.25 by $0.25. The business had revenue of $151.18 million during the quarter, compared to analysts' expectations of $151.55 million. UFP Technologies had a net margin of 11.40% and a return on equity of 21.54%. The company's quarterly revenue was up 37.2% compared to the same quarter last year. During the same period in the prior year, the business earned $1.86 earnings per share.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.